Copyright Reports & Markets. All rights reserved.

Global Nystatin API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nystatin API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Nystatin Non-micronized
    • 1.3.3 Nystatin Micronized
    • 1.3.4 Nystatin Compacted
  • 1.4 Market Analysis by Particle Size
    • 1.4.1 Overview: Global Nystatin API Consumption Value by Particle Size: 2021 Versus 2025 Versus 2032
    • 1.4.2 Particle Size <45μm
    • 1.4.3 Particle Size <10μm
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Nystatin API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 External Preparations
    • 1.5.3 Oral Preparations
  • 1.6 Global Nystatin API Market Size & Forecast
    • 1.6.1 Global Nystatin API Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Nystatin API Sales Quantity (2021-2032)
    • 1.6.3 Global Nystatin API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Antibiotice
    • 2.1.1 Antibiotice Details
    • 2.1.2 Antibiotice Major Business
    • 2.1.3 Antibiotice Nystatin API Product and Services
    • 2.1.4 Antibiotice Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Antibiotice Recent Developments/Updates
  • 2.2 Centrient Pharmaceuticals
    • 2.2.1 Centrient Pharmaceuticals Details
    • 2.2.2 Centrient Pharmaceuticals Major Business
    • 2.2.3 Centrient Pharmaceuticals Nystatin API Product and Services
    • 2.2.4 Centrient Pharmaceuticals Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Centrient Pharmaceuticals Recent Developments/Updates
  • 2.3 Duchefa Farma
    • 2.3.1 Duchefa Farma Details
    • 2.3.2 Duchefa Farma Major Business
    • 2.3.3 Duchefa Farma Nystatin API Product and Services
    • 2.3.4 Duchefa Farma Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Duchefa Farma Recent Developments/Updates
  • 2.4 VUAB Pharma
    • 2.4.1 VUAB Pharma Details
    • 2.4.2 VUAB Pharma Major Business
    • 2.4.3 VUAB Pharma Nystatin API Product and Services
    • 2.4.4 VUAB Pharma Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 VUAB Pharma Recent Developments/Updates
  • 2.5 Hubei Hengshuo Chemical
    • 2.5.1 Hubei Hengshuo Chemical Details
    • 2.5.2 Hubei Hengshuo Chemical Major Business
    • 2.5.3 Hubei Hengshuo Chemical Nystatin API Product and Services
    • 2.5.4 Hubei Hengshuo Chemical Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hubei Hengshuo Chemical Recent Developments/Updates
  • 2.6 Concord Biotech
    • 2.6.1 Concord Biotech Details
    • 2.6.2 Concord Biotech Major Business
    • 2.6.3 Concord Biotech Nystatin API Product and Services
    • 2.6.4 Concord Biotech Nystatin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Concord Biotech Recent Developments/Updates

3 Competitive Environment: Nystatin API by Manufacturer

  • 3.1 Global Nystatin API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nystatin API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nystatin API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nystatin API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nystatin API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nystatin API Manufacturer Market Share in 2025
  • 3.5 Nystatin API Market: Overall Company Footprint Analysis
    • 3.5.1 Nystatin API Market: Region Footprint
    • 3.5.2 Nystatin API Market: Company Product Type Footprint
    • 3.5.3 Nystatin API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nystatin API Market Size by Region
    • 4.1.1 Global Nystatin API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nystatin API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nystatin API Average Price by Region (2021-2032)
  • 4.2 North America Nystatin API Consumption Value (2021-2032)
  • 4.3 Europe Nystatin API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nystatin API Consumption Value (2021-2032)
  • 4.5 South America Nystatin API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nystatin API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nystatin API Sales Quantity by Type (2021-2032)
  • 5.2 Global Nystatin API Consumption Value by Type (2021-2032)
  • 5.3 Global Nystatin API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nystatin API Sales Quantity by Application (2021-2032)
  • 6.2 Global Nystatin API Consumption Value by Application (2021-2032)
  • 6.3 Global Nystatin API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nystatin API Sales Quantity by Type (2021-2032)
  • 7.2 North America Nystatin API Sales Quantity by Application (2021-2032)
  • 7.3 North America Nystatin API Market Size by Country
    • 7.3.1 North America Nystatin API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nystatin API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nystatin API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nystatin API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nystatin API Market Size by Country
    • 8.3.1 Europe Nystatin API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nystatin API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nystatin API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nystatin API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nystatin API Market Size by Region
    • 9.3.1 Asia-Pacific Nystatin API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nystatin API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nystatin API Sales Quantity by Type (2021-2032)
  • 10.2 South America Nystatin API Sales Quantity by Application (2021-2032)
  • 10.3 South America Nystatin API Market Size by Country
    • 10.3.1 South America Nystatin API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nystatin API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nystatin API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nystatin API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nystatin API Market Size by Country
    • 11.3.1 Middle East & Africa Nystatin API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nystatin API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nystatin API Market Drivers
  • 12.2 Nystatin API Market Restraints
  • 12.3 Nystatin API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nystatin API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nystatin API
  • 13.3 Nystatin API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nystatin API Typical Distributors
  • 14.3 Nystatin API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nystatin API market size was valued at US$ 39.20 million in 2025 and is forecast to a readjusted size of US$ 49.47 million by 2032 with a CAGR of 3.4% during review period.
    In 2025, global Nystatin API production reached approximately 128 tons, with an average global market price of around US$298 per kilogram. Nystatin API (Active Pharmaceutical Ingredient) is the raw material of a polyene - type antifungal drug. It is extracted from the culture broth of Streptomyces noursei and its main component is nystatin. It is a complex compound that belongs to the macrolide antibiotics family and has a conjugated polyene structure.
    The global Nystatin API market is characterized by steady, clinically driven demand for topical and oral antifungal formulations, alongside structural differentiation between small-scale reagent supply and larger pharmaceutical API supply. Production predominantly relies on traditional fermentation, with technical differentiation focused on impurity profiles and potency assays; regulatory scrutiny of complex, multi-component APIs has increased the compliance and documentation burden. Trends favor formulation-readiness (micronization), improved process consistency and downstream formulation innovation that can reduce costs and broaden application. Demand-side opportunities arise from consolidation among generic producers, improved access in emerging markets, and potential expansion into veterinary and combination topical products. Key barriers include the intrinsic complexity of fermentation-based manufacture, difficulty controlling related substances and stability, the high costs of demonstrating batch-to-batch consistency for registration, and supply risks from geographic concentration of production. Firms that invest in scalable fermentation controls, advanced impurity analytics, robust stability packages, GMP alignment and supply-chain diversification will be best placed to mitigate risks and capture incremental demand.
    This report is a detailed and comprehensive analysis for global Nystatin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nystatin API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Nystatin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Nystatin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Nystatin API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nystatin API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nystatin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antibiotice, Centrient Pharmaceuticals, Duchefa Farma, VUAB Pharma, Hubei Hengshuo Chemical, Concord Biotech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nystatin API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Nystatin Non-micronized
    Nystatin Micronized
    Nystatin Compacted
    Market segment by Particle Size
    Particle Size <45μm
    Particle Size <10μm
    Market segment by Application
    External Preparations
    Oral Preparations
    Major players covered
    Antibiotice
    Centrient Pharmaceuticals
    Duchefa Farma
    VUAB Pharma
    Hubei Hengshuo Chemical
    Concord Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nystatin API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nystatin API, with price, sales quantity, revenue, and global market share of Nystatin API from 2021 to 2026.
    Chapter 3, the Nystatin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nystatin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nystatin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nystatin API.
    Chapter 14 and 15, to describe Nystatin API sales channel, distributors, customers, research findings and conclusion.

    Buy now